FDA Inspection 1136893 — ENDO USA, Inc
The FDA completed an inspection of ENDO USA, Inc on Mar 3, 2021 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 3, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rye, NY (United States)